Pelatro Warrants Issue: ₹27.4 Cr (12 Nov 2026)
Pelatro Limited allotment of 6,85,000 convertible share warrants worth ₹27.4 crore approved
Pelatro · Media
Key highlights
- Board approved allotment of 6,85,000 convertible warrants at ₹400 each on Nov 12, 2026
- Warrants convertible into equal number of equity shares of face value ₹10 each within 18 months
- 9 allottees including promoters and public investors, upfront 25% payment received totaling ₹6.85 crore
Original filing
Outcome of Board Meeting
Read the filing on NSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentImagicaaworld EntertainmentImagicaaworld Entertainment reports Q2 & H1 FY27 financial results and strategic updates
- Fundraise / allotmentUnited Heat TransferUnited Heat Transfer Limited approves half-year financial results for Sept 2026
- Fundraise / allotmentJubilant PharmovaJubilant Pharmova reports Q2 and H1 FY27 financial results and operational updates
- Fundraise / allotmentNatural CapsulesNatural Capsules Limited approves Q2 2026 results and preferential allotment
- Fundraise / allotmentNatural CapsulesNatural Capsules Ltd announces Q2 FY27 results and approves preferential allotment
- Fundraise / allotmentDestiny Logistics & InfraDestiny Logistics & Infra Ltd announces key resignations, appointments, and warrant lapse
Potential multibaggers · Q2 FY27
Potential multibaggers in Media
on management's own guidance
- Bright OutdoorGood growth2
- Strong growth1
- Simca AdvertisingGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.